Abstract
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders whose etiology is multifactorial including both hereditary and environmental factors. Currently, pathogenic mutations in at least five genes have been implicated in familial PD generally accounting for less than 10 % of all PD cases in most populations. It has been suggested that polymorphisms in other genes such as those encoding enzymes involved in oxidative metabolism and detoxification could be involved in predisposition to PD since oxidative stress in dopaminergic neurons is thought to be of central importance in the pathogenesis of the disease. The aim of our work was to study the association of genetic polymorphisms in genes involved in oxidative metabolism and detoxification mechanism, namely GSTM1, GSTT1, GSTP1, and those involved in DNA damage repair, OGG1 and XRCC1, in an Italian cohort of sporadic PD patients. We did not detect any association between GSTT1 and GTTM1 null polymorphisms and PD, whereas the 104GSTP1 polymorphism was associated with PD in male patients but not in females. Furthermore, we detected a protective effect of wild type genotype of XRCC1 in women.
Similar content being viewed by others
References
Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson’s disease. J Neurol 255:18–32
Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B (1997) Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324:25–28
Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398–406
Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214
Coppedè F, Ceravoloa R, Migheli F, Fanucchi F, Frosini D, Siciliano G, Bonuccelli U, Migliore L (2010) The hOGG1 Ser326Cys polymorphism is not associated with sporadic Parkinson’s disease. Neurosci Lett 473:248–251
Cornetta T, Festa F, Testa A, Cozzi R (2006) DNA damage repair and genetic polymorphisms: assessment of individual sensitivity and repair capacity. Int J Radiat Oncol Biol Phys 66:537–545
Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD (2004) Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson’s disease. Neurosci Lett 366:326–331
Dogru-Abassoglu S, Aykac-Toker G, Hanagasi HA, Gurvit H, Emre M, Uysal M (2007) The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer’s disease. Neurol Sci 28:31–34
Evangelou E, Maraganore DM, Ioannidis JPA (2007) Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE 2:c196
Fukae J, Takanashi M, Kubo S, Nishioka K, Nakabeppu Y, Mori H et al (2005) Expression of 8-oxoguanine DNA glycosylase (OGG1)in Parkinson’s disease and related neurodegenerative disorders. Acta Neuropathol (Berl) 109:256–262
Gelb D, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson’s syndromes: a critical review. Curr Opin Genet Dev 19:254–265
Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson’s disease. Acta Neuropathol 124:325–338
Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26–36
Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T et al (2003) Glutathione-S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett 337:5–8
Kiyohara C, Miyake Y, Koyanagi M et al (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord 16:447–452
Lill CM et al (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: the PDGene database. PLoS Genet 8:1–10
Martin LJ (2008) DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol 67:377–387
Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R et al (2002) Oxidative damage and cytogenetic analysis in leukocytes of Parkinson’s disease patients. Neurology 58:1809–1815
Nakabeppu Y, Kajitani K, Sakamoto K, Yamaguchi H, Tsuchimoto D (2006) MTH1 an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. DNA Repair (Amst.) 5:761–772
Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K (2007) Oxidative damage in nucleic acids and Parkinson’s disease. J Neurosci Res 85:919–934
Nishimura M, Kuno S, Kaji R, Yasuno K, Kawakami H (2005) Glutathione-S-transferase-1 and interleukin-1 beta gene polymorphisms in Japanese patients with Parkinson’s disease. Mov Disord 20:901–902
Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci 22:123–144
Parildar-Karpuzoglu H, Dogru-Abassoglu S, Hanagasi HA, Karadag BH, Gurvit H, Emre M et al (2008) Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer’s disease. Neurosci Lett 442:287–291
Perez-Pastene C, Graumann R, Diaz-Grez F, Miranda M, Venegas P, Godoy OT et al (2007) Association of GSTM1 null polymorphism with Parkinson’s disease in a Chilean population with a strong Amerindian genetic component. Nurosci Lett 418:181–185
Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Del Dotto P, Migliore L et al (2001) Cytogenetic analysis oxidative damage in lymphocytes of Parkinson’s disease patients. Neurol Sci 22:83–84
Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41:1303–1307
Sherer TB, Betarbet R, Greenamyre JT (2001) Pathogenesis of Parkinson’s disease. Curr Opin Investig Drugs 2:657–662
Shinmura K, Yokota J (2001) The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 3:597–609
Simón-Sánchez J, Schulte C, Bras JM, Sharma M, Gibbs JR et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312
Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D (2008) Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 312:131–138
Tan EK (2007) The role of common genetic risk variants in Parkinson disease. Clin Genet 72:387–393
Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM et al (2011) VPS35 mutations in Parkinson disease. Am J Hum Genet 89:162–167
Wahner AD, Glatt CE, Bronstein JM, Ritz B (2007) Glutathione-S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson’s disease. Neurosci Lett 413:274–278
Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson’s disease. Ann Neurol 53:S16–S25
Wilson DM, McNeill DR (2007) Base excision repair and the central nervous system. Neuroscience 145:1187–1200
Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821–1824
Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 89:168–175
Acknowledgments
The authors thank Tamara Ialongo for patient database management and DNA sample extraction. This paper was supported by a Grant (Ricerca Scientifica 2008–2009) from Don Carlo Gnocchi Foundation, Italy.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cornetta, T., Patrono, C., Terrenato, I. et al. Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms. Cell Mol Neurobiol 33, 673–680 (2013). https://doi.org/10.1007/s10571-013-9933-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-013-9933-8